Conference · Economics & Finance

SITC 2026 Abstract Submission Guidelines and Policies

Submit your abstract for free for the opportunity to present and discuss your research with luminaries in the immunotherapy field. SITC 2026 features multiple oral presentations and Early Career Investigator Awards.

In short

SITC 2026 Abstract Submission Guidelines and Policies was a conference on economics & finance held in United States, on 8 Nov 2026.

SITC 2026 Abstract Submission Guidelines and Policies banner

About this event

SITC 2026 features multiple oral presentations and Early Career Investigator Awards. All accepted abstracts will be published as a supplement in the Journal for ImmunoTherapy of Cancer (JITC), the society’s global, open access, peer-reviewed journal.

The time frame to submit your latest research in the cancer immunotherapy field to the 41st Annual Meeting for consideration as an oral abstract presentation and/or poster abstract presentation is April 22, 2026 until 5 p.m. PT on June 25, 2026.

Regular Abstracts with primary and presenting authors that are students, postdoctoral research fellows, clinical fellows, or junior faculty with three or fewer years on staff and are current SITC members, may be eligible to receive an Early Career Investigator Award. Early Career Investigator Award Abstracts require a letter of recommendation as well as additional information regarding the percentage of contribution by the primary and presenting author. The time frame to submit a Early Career Investigator Award Abstract to the 41st  Anniversary Annual Meeting is April 22, 2026 until 5 p.m. PT on June 25, 2026.

Those selected for the Presidential Travel Award will be invited to give an oral abstract presentation during the Presidential Session from 9:05–10:30 a.m. on Sunday, Nov. 8, 2026 (session time subject to change). An abstract submitted for an Early Career Investigator Award that does not receive an award may still be accepted as an abstract for SITC 2026 and will be considered a Regular Abstract. 

View more information about the Early Career Investigator Awards, as well as the criteria and eligibility.

Late-breaking Abstract - Clinical Only (LBA) submission is solely for abstracts with late-breaking data from interventional clinical trials in humans and not for abstracts submitted “late”. The LBA deadline is not intended to be an extension of the general submission deadline. LBAs highlight novel and practice-changing in-human clinical studies and only apply to data that would have not otherwise have been presented as an abstract at the 41st Annual Meeting. 

Listed by the organizer on 6 Nov 2026, last updated . Check dates and fees on the official website before booking travel. Report a problem with this listing.